SWX:IDIABiotechs
Idorsia (SWX:IDIA) Stock Could Be 48% Below Fair Value After Debt Refinance
Idorsia (SWX:IDIA) has agreed to a senior secured term loan of up to CHF 250 million with funds managed by Pharmakon Advisors, refinancing its existing New Money Facility and removing near term debt maturities.
See our latest analysis for Idorsia.
Idorsia's debt refinancing news lands after a sharp shift in sentiment, with the 90 day share price return of 84.34% and 1 year total shareholder return of 208.23% contrasting with weaker 3 and 5 year total shareholder returns. This suggests...